Tom Murphy | Associated Press
AP Health Writer-
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.
© 2024 WPSU
Public Media for Central Pennsylvania
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
